ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors

BACKGROUND: Decreased expression of the angiogenesis inhibitor ADAMTS1 (ADAM metallopeptidase with thrombospondin type 1 motif, 1) has previously been reported during prostate cancer progression. The aim of this study was to investigate the function of ADAMTS1 in prostate tumors. METHODS: ADAMTS1 wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gustavsson, Heléne, Tešan, Tajana, Jennbacken, Karin, Kuno, Kouji, Damber, Jan-Erik, Welén, Karin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894797/
https://www.ncbi.nlm.nih.gov/pubmed/20546609
http://dx.doi.org/10.1186/1471-2407-10-288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894797/
https://www.ncbi.nlm.nih.gov/pubmed/20546609
http://dx.doi.org/10.1186/1471-2407-10-288

Ejemplares similares